All News

Found 2,730 articles

• AUM LifeTech Develops A New Approach To Combat HIV By Using FANA RNA Silencing Technology To Inhibit HIV Replication

  10/6/2016

• Bio-Rad Launches Nuvia IMAC Affinity Resin For Process Scale Purifications At Bioprocess International Conference And Exhibition 2016

  10/5/2016

• Massachusetts VC-Backed Biotech Ra Pharma Files for $86 Million IPO

  10/3/2016

• Boston Children's Hospital Release: Researchers Reveal How Dangerous Intestinal Toxin Enters Cells

  9/29/2016

• Advanced Cell Diagnostics Launches BaseScope Suite Of Tissue Analysis Assays Enabling Breakthrough Advances In Molecular Pathology

  9/28/2016

• Silence Therapeutics Release: Interim Results For The Six Months Ended 30 June 2016

  9/27/2016

• Breakthrough Gene Technology Attracts Investors Amid Patent Dispute

  9/26/2016

• Abeona Therapeutics Enrolls First Patient In Phase 2 For EB-101 Gene Therapy Clinical Trial For Epidermolysis Bullosa

  9/26/2016

• Caribou Biosciences’ President And CEO Rachel Haurwitz Named To Fortune’s 2016 "40 Under 40" List Of Most Influential Young People In Business

  9/26/2016

• Oncolinx Receives Three Months Of Free Bench On Demand Space At Mass Innovation Labs

  9/22/2016

• Homology Medicines Acquires License To Novel AAV Technology To Develop Treatments For Central Nervous System Disorders

  9/15/2016

• Allele Biotechnology Receives NIH Award To Fund The Development Of Large-Scale Stem Cell Production

  9/14/2016

• Gene Editing Phenom CRISPR Files for $90 Million IPO

  9/12/2016

• Poseida Therapeutics Establishes Scientific Advisory Board

  9/8/2016

• The Alliance for Regenerative Medicine (ARM) Releases Agenda For 2016 Cell & Gene Meeting On The Mesa

  9/7/2016

• Horizon Discovery Ltd. And Fulcrum Therapeutics Form Collaboration For Novel CRISPR-Based Target Discovery In Genetic Diseases

  9/6/2016

• BIO Investor Forum 2016 Programming Announced

  9/6/2016

• Caribou Biosciences Appoints Vonnie Estes As Group Leader, Agricultural And Industrial Biotechnology

  8/30/2016

• Abeona Therapeutics Completes Enrollment Of Low-Dose Cohort For ABO-102 In Phase 1/2 Clinical Trial For MPS IIIA Patients

  8/29/2016

• Bayer and CRISPR Form 80 Employee Joint Venture Named Casebia Therapeutics in Boston Area

  8/22/2016